Claritas Pharmaceuticals Inc CLAZF

RE:MD&A .....!!!

[Dude51]

Since its inception in July 2014, Claritas has accumulated a deficit of approximately $59.2 million as at June 30, 2021. The Company did not generate any revenue from product sales during the three months period ended June 30, 2021. Claritas expects its operating losses to continue in the next fiscal year as it invests in its product development programs. The Company has funded its operations with proceeds from equity and convertible debt financings and expects to seek additional funding through equity financings and partnership collaborations to finance its product development, and corporate growth. However, if Claritas’ product development activities do not show positive progress, or if capital market conditions in general or with respect to the life sciences sector or development stage companies such as Claritas are unfavorable, its ability to obtain additional funding will be adversely affected.

$59.2 million because of good management decions? Sorry but this is reality.